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Abstract 
Purpose: To examine associations between adherence to a Mediterranean diet and 
prevalence of AMD in countries ranging from Southern to Northern Europe. 
Design: Cross-sectional population based epidemiological study. 
Participants: Of 5060 randomly sampled people aged 65 or over from 7 study 
centers across Europe (Norway, Estonia, United Kingdom, France, Italy, Greece, 
and Spain) full dietary data were available in 4753. The mean age of participants 
was 73.2 (SD, 5.6) and 55% were women. 
Methods: Participants underwent an eye examination and digital retinal color 
photography. The images were graded at a single center.  Dietary intake during the 
previous 12 months was assessed by using a semi-quantitative food-frequency 
questionnaire (FFQ).  A previously published Mediterranean Diet Score (MDS) was 
used to classify participants according to their responses on the FFQ.  Multivariable 
logistic regression was used to investigate the association of MDS score and 
AMD.taking account of potential confounders and the multicentre study design. 
Main outcome measures: Photographic images were graded according to the 
International Classification System for age-related maculopathy  and stratified using 
the Rotterdam staging system into 5 exclusive stages (AMD 0-4) and a separate 
category of large drusen (≥125 µm). AMD4 included neovascular AMD (nvAMD) or 
geographic atrophy (GA). 
Results: Increasing MDS was associated with reduced odds of nvAMD in 
unadjusted and confounder adjusted analysis. Compared with the lowest MDS 
adherence (≤4 score) those in the highest category MDS adherence (>6 score) 
showed lower odds of nvAMD, OR=0.53 (0.27-1.04), p-trend=0.01). The association 
with MDS did not differ by Y204H (p=0.89).  For all early AMD (grade 1-3), there was 
not relationship with MDS, p trend=0.9. There was a weak trend (p=0.1) between 
MDS and large drusen, those in the highest category of MDS had a 20% reduced 
odds compared to those in the lowest, p=0.05.   
Conclusions: This study adds to the limited evidence of the protective effect of 
adherence to a Mediterranean dietary pattern and late AMD though does not support 
previous reports of a relationship with genetic susceptibility.  Interventions to 
encourage the adoption of the Meditterranean diet should be developed and 
methods by which such behaviour change can be achieved and maintained 
investigated. 
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Introduction 
Age-related macular degeneration (AMD) is the predominant cause of blindness in 
high income countries1.  It is of growing importance in other settings, in association 
with increasing longevity.2 AMD is considered to be a complex multi-factorial 
disorder, involving an interplay between genetic, environmental and lifestyle factors, 
such as smoking,3 obesity,4 cardiovascular disease,5 macular pigment,6 sunlight 
exposure,7 diet,8 high BMI9 and physical activity10. 
 
It has been known for some time that dietary factors can modulate AMD risk11 12.  
Epidemiological studies have demonstrated that diets high in antioxidant nutrients 
(vitamins C and E, carotenoids such as lutein and zeaxanthin and fruit and 
vegetables rich in these nutrients) or zinc are associated with a decreased 
occurrence of AMD. Studies have also shown that a high dietary intake of trans fats 
is a risk factor for late AMD,13 while a higher intake of fish or ω –3 fatty acids is 
protective against AMD13.   However the evidence from clinical trials is less 
consistent. While high dose multivitamin supplementation slowed the progression of AMD,14 
a trial which added lutein and zeaxanthin supplements with or without omega-3 fatty acids to 
the AREDS supplements showed no substantial added beneficial effect of the AREDS 
supplements on AMD progression (AREDS2).15  However, in the pre-specified analyses of 
those persons with the lowest dietary intake of lutein, there was a beneficial effect of lutein 
for retarding the progression to late AMD, especially the neovascular form.16. Most studies 
to date have focused on individual food groups or nutrients, yet it is known that diet 
is a multifactorial lifestyle behaviour, with particular foods frequently consumed 
together, depending on the cultural, geographical and economic context of the 
individual.  Therefore researchers are increasingly attempting to analyse 
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relationships between dietary patterns or overall diet and disease, rather than 
specific foods or nutrients17 18 20.  To date these analyses have been undertaken in 
populations living in defined geographical locations such as Melbourne, Australia,17 
US CAREDS participants19 or in US AREDS participants 18 20 consequently, there is 
a greater likelihood that the dietary patterns of the individuals in these studies was 
similar. This was particularly evident in the application of a Mediterranean diet score 
to CAREDS participants19 in that high scores were uncommon in this sample 
(0.04%).    As dietary patterns vary by culture, and availability of local food is subject 
to strong regional influences, a lack of heterogeneity of populations in the prior 
studies may have reduced the power to detect associations with AMD outcomes.  By 
contrast the European Eye (EUREYE) Study enrolled participants from 7 countries 
across Europe with widely differing cultures and dietary patterns, thus providing an 
interesting context in which to investigate links between diet and AMD.  Notably the 
dietary questionnaire was modified to reflect locally available foods.  For these 
reasons we aimed to examine the association between adherence to a 
Mediterranean diet and prevalence of AMD in countries ranging from Southern to 
Northern Europe.                                                                          
 
Methods 
Study Population 
We recruited participants between 2001 and 2002 from seven European countries 
(Bergen, Norway; Tallinn, Estonia, Belfast, UK; Paris, France; Verona, Italy; 
Thessaloniki, Greece; and Alicante, Spain) using random sampling of the population 
aged over 65 years.  Written informed consent was obtained from all study 
participants. Ethical approval was obtained for each country from the relevant ethics 
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committee and the study adhered to the Declaration of Helsinki on research into 
human volunteers.  
The study design and methodology has been published elsewhere 7 21-26.  
Participants attended the examination center, where they were first interviewed by 
trained fieldworkers, underwent an ophthalmological examination and gave a blood 
sample. Information collected by the interviewers included quantified smoking and 
alcohol use and a brief medical history, detailed questionnaire on outdoor exposure 
throughout working life and in retirement, and a dietary assessment (described in 
detail below).  
Dietary Assessment Methodology 
During the interview, dietary intake during the previous 12 months was assessed by 
using a semi-quantitative food-frequency questionnaire (FFQ). We used the UK 
European Prospective Investigation into Cancer and Nutrition (EPIC) Study FFQ27, 
which was derived from the original FFQ devised by Willett28. For each non-United 
Kingdom country in the study, we modified the FFQ for food items that were 
redundant or relevant using the EPIC country-specific questionnaires to identify 
additional food items or the local variety of a food item. In Estonia, where there was 
no equivalent EPIC questionnaire, we devised the FFQ after consultation with local 
nutrition researchers. Validation studies have been carried out on country-specific 
EPIC questionnaires, e.g., for the United Kingdom27.  In addition, among the Spanish 
participants, we explored the relation between energy-adjusted dietary carotenoid 
and vitamin C intakes and serum concentration. Significant Pearson correlations 
were observed for alpha-carotene 0.21, β-carotene 0.19, lycopene 0.18, β-
cryptoxanthin 0.20 and vitamin C 0.36, which support an acceptable performance of 
the dietary intakes estimated from the FFQ.29  Information on habitual consumption 
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of foods during the previous year included portion size and was recorded in 9 
different frequency categories, from never or less than once a month to 6 times/day 
or more.  Intake of food items was recorded into portions per day. Nutrient intake 
was estimated using the food-composition tables of McCance and Widdowson30 and 
EPA and DHA intake using US Department of Agriculture tables31, because EPA and 
DHA were not available in the table of McCance and Widdowson30. For each study 
participant, the nutrient intake was calculated by multiplying the intake frequency for 
each food item by the nutrient content for the portion size. Dietary intakes were 
adjusted by energy using the residual method.  
 
Assessing adherence to Mediterranean Diet Score (MDS) 
We used a previously published MDS to classify participants according to their 
responses on the FFQ.32  The composite score (range 0-9) captures consumption of 
key food items, such as olive oil (1 point for > 1 spoon/day), wine (1 point for > 1 
glass/day), fruit (1 point for > 1 serving/day), vegetables or salad (1 point for > 1 
serving/day), fish (1 point for > 3 servings/week), legumes (1 point for > 2 
servings/week) and low consumption of meat or meat products (1 point for < 1 
serving/day). A further point was awarded for a daily serving or more of both fruits 
and vegetables, and a final point was awarded when either consumption of both 
white bread (<1 serving/day) and rice (< 1 serving/week) was low or when 
consumption of whole-grain bread was high (>5 servings/week). 
 
Assessment of age-related macular degeneration.  
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After pupillary dilation with tropicamide 0.5% and phenylephrine 5%, two 35° non-
simultaneous stereoscopic digitized color fundus images were obtained of each eye, 
centered on the fovea. 
 
The fundus images were sent to a single reading centre (Erasmus University 
Rotterdam) and graded using the International Classification System for Age-Related 
Maculopathy33 and then categorised into five mutually exclusive grades.  Grade 0 
was defined as a macula free of drusen or pigmentary irregularities or with hard 
drusen (<63 µm) only. Early AMD was subdivided in grade 1, defined as soft distinct 
drusen (≥63 µm) or pigmentary abnormalities; grade 2 was defined as soft indistinct 
drusen (≥125 µm) or reticular drusen only or soft distinct drusen (≥63 µm) with 
pigmentary abnormalities; and grade 3 was defined as soft indistinct drusen (≥125 
µm) or reticular drusen with pigmentary abnormalities.  Grade 4 was defined as 
presence of either neovascular (nvAMD) [presence of any of the following: serous or 
hemorrhagic retinal or retinal pigment epithelial detachment, subretinal neovascular 
membrane, periretinal fibrous scar] or geographic atrophy (GA) [well-demarcated 
area of retinal pigment atrophy with visible choroidal vessels]).  This grading system 
had been validated within the Rotterdam Eye  Study.34 Large drusen (≥125 µm) in 
any grade of early AMD were additionally categorised as a separate outcome. 
 
Blood Samples 
A non-fasting blood sample was collected.  Participants were advised to consume a 
standard breakfast before attending the clinic, e.g. not eating fruit and fruit juice prior 
to coming into the centre.  Samples were anti-coagulated with EDTA or were allowed 
to clot.  Samples were kept at room temperature for at least one hour (serum) or kept 
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at 4C and centrifuged as soon as possible (plasma), but all samples were 
centrifuged a maximum of 2 hours after collection.  Serum or plasma was aliquoted 
as required for biochemical analysis.  A plasma sample was precipitated by adding 
100 l of plasma to 900 l of 5% metaphosphoric acid for vitamin C analysis, and all 
samples were stored at either -20C or less than -70C in the short term (depending 
on what was locally available) and shipped at regular intervals to the Belfast centre 
(the biochemical analysis centre) where they were stored at -80C. DNA was 
extracted from the stored blood sample and genotyped for Y204H (rs1061170). 
Plasma ascorbic acid concentrations were determined according to Vuillemier and 
Keck35. Serum concentrations of retinol, α-tocopherol, lutein, zeaxanthin, β-
cryptoxanthin, -carotene, β-carotene and lycopene were measured by reverse 
phase high performance liquid chromatography (HPLC)36. Assays were standardised 
against appropriate National Institute of Standards and Technology reference 
materials.  
 
Statistical analysis 
Statistical analysis was carried out using Stata version 13 (Stata Corp, College 
Station, Texas). We categorised the MDS score into 4 groups (MDS of <=4; 5; 6; >6) 
as this provided a more even spread across groups.  We used univariable regression 
in people without signs of AMD to investigate potential confounders expected to be 
associated with MDS and AMD, either negatively or positively: demographic (age, 
sex and education) lifestyle (smoking, alcohol, body mass index, and supplement 
use), comorbidity (diabetes, cardiovascular disease). We also investigated the 
relationship between MDS and dietary and serum biomarkers of nutritional status 
related to food groups which predominate within the MDS. Blood analyses were 
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seasonally adjusted and dietary nutrients were energy adjusted. We undertook 
multivariable logistic regression to investigate the association of MDS score with 
AMD and with large drusen. We investigated whether rs1061170 modified any 
association with AMD and diet score as has been previously reported.20  All analyses 
took account of the study design of the seven study centers by use of survey 
estimators or robust errors.   
 
Results 
Of 5040 EUREYE participants, full dietary data was available in 4753 participants 
(109 nvAMD, 49 with GA, 2333 early AMD, 641 with large drusen and 2262 without 
signs of AMD.  The mean age of participants was 73.2 (SD, 5.6) and 55% were 
women. 
 
MDS and participant characteristics 
In univariable analysis in people with no signs of AMD, significant trends were 
observed for MDS score with sex, education, and alcohol intake, but no association 
with age (Table 1).  There were decreasing proportions of women in higher MDS 
categories, and conversely increasing proportions of those with higher education 
levels and weekly or more alcohol consumption. Smoking and being overweight or 
obese, history of diabetes or cardiovascular disease were not linearly associated 
with MDS category.  There were highly significant differences in the MDS score 
across the participating EUREYE countries with the southern European countries 
having higher MDS compared to those in the Northern regions.  Mean (SD) values 
for the individual countries were as follows: Norway (Bergen) 4.89 (1.39), Estonia 
(Tallinn) 4.49 (1.11), UK (Belfast) 4.42 (1.30), France (Paris) 4.62 (1.50), Italy 
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(Verona) 5.37 (1.18), Greece (Thessaloniki) 5.19 (1.09), Spain (Alicante) 5.32 (1.39), 
p<0.0001.  Figure 1 illustrates the proportion of participants in each country reporting 
a particular item of the MDS score.  Age-standardised mean (95% CI) MDS scores 
by AMD grade showed a weak trend from no AMD to late AMD. AMD 0 5.03 (4.6-
5.5), AMD 1 5.02 (4.6-5.4), AMD 2 5.08, 4.7-5.5) AMD 3 4.97 (4.5-5.5), AMD 4 4.76 
(4.3-5.2), p for trend = 0.16.    
 
MDS and serum levels of antioxidants 
Table 1 also shows the relationship between MDS and serum antioxidant levels.  
The MDS diet score correlated well with serum levels of vitamin C, lutein, zeaxanthin 
and beta-cryptoxanthin, all biomarkers of fruit and vegetable intake.  MDS was also 
negatively associated with saturated fatty acid and n-6 PUFA intake and positively 
associated with n-3 PUFA intake and dietary lutein plus zeaxanthin. 
 
MDS and late AMD (nvAMD and GA) 
Increasing MDS was significantly associated with reduced odds of nvAMD (Table 2), 
in both the unadjusted analysis and also when adjusted for potential confounders 
such as age, sex, country, education, smoking, drinking, self-reported history of 
CVD, aspirin consumption and diabetes.  A score of >6 was associated with an 
approximately 50% reduction in the adjusted odds ratio of developing nvAMD 
compared to those with a score of 4 or less.   
 
Preliminary analyses showed no association with GA and we did not run further 
analyses on GA with full data on diet score and confounders.  
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MDS and early AMD (grade 1-3)  
For all early AMD participants (grades 1-3), there was no significant relationship with 
MDS (Table 3). There was a weak trend (p=0.1) between MDS and large drusen, 
those in the highest category of MDS had a significant 20% reduced odds compared 
to those in the lowest, p=0.05. Addition of plasma or dietary lutein and zeaxanthin did 
not affect the results for early AMD or large drusen. 
 
We also examined whether the results for the diet score varied according to Y204H 
(rs1061170) genotype. We found no significant interactions between rs1061170 and 
the full diet score in the association with nvAMD (p=0.89), early AMD (p=0.28) or 
large drusen, p=0.99. We further explored whether the association with diet score 
was explained by the key macular carotenoids lutein and zeaxanthin. Addition of 
either dietary or plasma lutein and zeaxanthin made no material difference to the 
results for the diet score for any outcome.  
 
Discussion 
The current analysis has exploited the large regional differences in food consumption 
found in the EUREYE study to examine the relationship between diet and AMD in 
Europe.  We have shown that increased adherence to a Mediterranean diet was 
associated with significantly reduced odds of having nvAMD.  MDS has previously 
been inversely associated with cardiovascular disease, cancer and mortality37-39 and 
more recently progression to advanced AMD20.  Our current findings provide further 
evidence for the potential value of adhering to this diet on eye health.   
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We did not find a significant association between early AMD and MDS. However the 
classification of early AMD was based on color image grading which may not detect 
some features of early AMD. Many of the individual constituents of the MDS have 
previously been identified as associated with reduced prevalence of incidence of 
AMD, such as higher fruit and vegetable40, reduced red meat41, lower glycaemic 
index42 and higher fish intake23.  It is also interesting that carotenoids such as lutein 
and zeaxanthin, which have well-established associations with AMD, but are also 
established biomarkers of fruit and vegetable intake, were significantly associated 
with MDS in those without signs of AMD.  However the association we observed 
between MDS and neovascular AMD was not explained by lutein and zeaxanthin. 
This is not surprising because the MDS score is based on hypothesised benefits of 
food patterns rather than single nutrients and therefore includes other important 
nutrients relevant to late AMD.  
 
Dietary patterns rather than individual components are increasingly being studied in 
relation to AMD.  Various methodological approaches have been taken but tend to 
fall into two broad categories.  The first are a posteriori approaches, including the 
use of factor and principal component analysis to identify patterns which are then 
related to the disease under investigation.17 18 This is a data driven approach, and 
requires no a priori hypothesis of what factors or food groups within the overall diet 
may be important.  The second method uses a priori scores to assess an individual’s 
adherence to a specific diet such as the Mediterranean diet20 or a set of dietary 
recommendations41 43, and therefore requires an a priori hypothesis of what may be 
significant.  In this analysis, we have used the latter approach.  
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Several studies have evaluated dietary patterns and AMD. In the Melbourne 
Collaborative Cohort Study principal components analysis revealed 6 distinct dietary 
factors, the factor characterized by high fruit and nut intake demonstrated a similar 
risk reduction for advanced AMD to the current study (0R 0.45; 95% confidence 
interval, 0.28-0.87).17 Conversely a diet characterised by high cakes, sweet biscuits 
and desserts was associated with a higher prevalence of advanced AMD.  No 
significant associations were reported between early AMD and dietary factors. 
Evaluation of dietary data from the baseline Age-related eye disease study (AREDS) 
identified two major components which the investigators named Oriental and 
Western patterns 24.  The oriental pattern was associated with significantly reduced 
odds of both early and advanced AMD while the western patterns was associated 
with significantly increased odds of both early and advanced AMD.  While the 
associations were noted for both early and advanced AMD, the strength of the 
associations were much greater for advanced AMD.  A score based approach has 
been applied within the Carotenoids in Age-related Eye Disease Study (CAREDS). 
Responses to a food frequency questionnaire were converted to a modified 2005 
Healthy Eating Index and those in the highest quintile compared to the lowest 
quintile of the index had 46% lower odds of developing early AMD19. Most recently, 
in an analysis of the association of adherence to the Mediterranean diet and genetic 
susceptibility with progression to advanced AMD, higher adherence to the 
Mediterranean Diet was associated with reduced risk of progression to advanced 
AMD; the association was only seen in subjects carrying the carrying none or one 
CFH Y402H risk alleles and not observed in those at the highest risk with two 
alleles20.  In our analysis we did not find that the association of diet score with AMD 
was modified by Y204H alleles. The small number of cases with nvAMD meant we 
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lacked power to investigate significant gene/diet interactions (as found  in that 
paper),  but had adequate numbers for analyses in early AMD. 
 
One of the strengths of our study in a European older population was that it was 
carried out prior to the widespread usage of supplements for AMD and also prior to 
public awareness of the relationship between dietary factors and AMD, thereby 
reducing the potential of recall bias by those with a diagnosis of AMD.  In addition 
the grading of the fundus photographs was undertaken by independent graders with 
no knowledge of any characteristics of the participants including the nutrition data.  
Comparison of the MDS score with serum antioxidants also provides us with a 
helpful insight into what constituents of the diet that the MDS is reflecting (Table 1). It 
also provides a degree of construct validity to the MDS score.   
 
This is a cross-sectional study therefore no causal inferences can be made 
regarding the associations noted.  This study was also carried out prior to the routine 
use of Optical Coherence Tomography in characterising AMD features, therefore 
some of the early features of AMD may have been misclassified and important 
phenotypes such as reticular pseudo drusen under-ascertained through the sole use 
of colour fundus photographs.  Dietary intake, including calculation of MDS, was 
based on a self-reported food frequency questionnaire.  Such a questionnaire, 
although commonly used in nutritional epidemiology, can be prone to bias, including 
over-reporting of healthy foods, such as those contained within the MDS. 
 
In conclusion, this study provides further evidence of the relationship between 
Meditterean diet and prevalence of AMD.  The MDS provides a useful method to 
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characterise dietary patterns ascross geographically and culturally diverse 
populations.  Interventions to encourage the adoption of the Meditterean diet more 
widely should be developed.  While methods by which such behaviour change can 
be achieved and maintained over the long term should be investigated.   
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Figure 1.  Proportion of participants in each country within the EUREYE study 
reporting a particular item of the MDS. 
 
 
 
The MDS score ranges from 0-9.  The 9 points can be awarded according to 
consumption of the following dietary items: Olive oil (1 point for >1 spoon/day); wine 
(1 point for > 1 glass/day); fruit (1 point for > 1 serving/day); vegetables or salad (1 
point for > 1 serving/day); fish (1 point for > 3 servings/week); legumes (1 point for > 
2 servings/week); meat or meat products (1 point for < 1 serving/day).  A further 
point was awarded if a participants when > 1 serving/day of both fruits and 
vegetables was consumed, and a final point was awarded for wholegrain 
consumption [when either consumption of both white bread (<1 serving/day) and rice 
(< 1 serving/week) was low or when consumption of whole-grain bread was high (>5 
servings/week)].  
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Table 1 Characteristics by category of diet score in 2262 people with no signs of 
AMD 
 
 
 
1 Mean (SD) 
2 % (n) 
 Mediterranean Diet Score   
Characteristics   ≤4 
(n=787) 
5     
( n=749) 
6   
(n=527) 
>6 (n=199) p trend* 
      
Age1 72.6 (5.5) 72.6 (5.3) 72.6 (5.3) 72.4 (5.2) 0.64 
Women 2 58.3 (459) 56.3 (422) 50.1 (264) 44.7 (89) 0.10 
Education  (lowest 
tertile of years)2 
40.6 (317) 47.2 (352) 47.2 (248) 61.6 (122) 0.02 
Ever smoker 2 48.3 (380) 44.2 (331) 49.1 (258) 58.3 (116) 0.05 
Alcohol at least 
weekly2 
31.9 (249) 38.4 (287) 46.8 (246) 67.3 (134) 0.01 
Overweight & 
Obese2 
73.5 (555) 83.2 (612) 81.1 (612) 81.1 (159) 0.01 
Diabetes2 11.6 (90) 13.8 (103) 14.3 (75) 12.1 (24) 0.48 
Cardiovascular 
Disease2 
11.9 (101) 12.6 (97) 16.4 (85) 11.6 (24) 0.16 
Aspirin use 36.9 (283) 39.2 (284) 41.9 (209) 43.4 (81) 0.27 
Supplement use2 33.0 (228) 30.2 (225) 35.5 (186) 26.9 (53) 0.44 
Blood antioxidants  
µmol/L 
     
Vitamin C1, 41.8 (26.4) 46.2 (24.1) 44.3 (21.4) 46.5 (22.3) 0.05 
Retinol1 2.23 (0.80) 2.24 (0.77) 2.21 (0.77) 2.26 (0.75) 0.46 
Lutein1 0.15 (0.15) 0.17 (0.17) 0.19 (0.18) 0.22 (0.20) 0.02 
Zeaxanthin 1 0.03 (0.03) 0.04 (0.03) 0.04 (0.03) 0.05 (0.03) 0.01 
Lycopene1 0.74  
(0.78) 
0.73 (0.79) 0.84 (0.82) 0.92 (0.93) 0.02 
Alpha –carotene1 0.10 (0.11) 0.097 (0.10) 0.11 (0.11) 0.11 (0.10) 0.16 
Beta-carotene1 0.36 (0.36) 0.36 (0.35) 0.41 (0.39) 0.42 (0.39) 0.06 
Beta-cryptoxanthin 
1   
0.08 (0.10) 0.10 (0.11) 0.11 (0.13) 0.13 (0.14) 0.01 
Alpha- tocopherol1  29.8 (7.16) 30.12 (7.03) 30.0 (7.0) 31.2 (7.10 0.16 
Gamma- 
tocopherol1   
2.65 (1.36) 2.64 (1.36) 2.61 (1.39) 2.36 (1.12) 0.47 
Total carotenoids1,3  
µmol/L 
1.37 (1.23) 1.34 (1.16) 1.52 (1.29) 1.73 (1.53) 0.01 
Dietary Variables 
g/day 
     
Saturated FAs  26.6 (6.5) 24.3 (6.2) 22.5 (6.4) 21.2 (5.7) <0.0001 
Total N-3PUFAs 1 1.72 (0.45) 1.96 (0.57) 2.09 (0.60) 2.19 (0.63) <0.001 
Total N-6PUFAs 1 9.14 (2.37) 8.61 (2.43) 8.36 (2.30) 8.11 (2.22) 0.01 
Lutein/ zeaxanthin 4 1646 
(996,3065) 
2491 
(1447,4513) 
3043 
(1821,5370) 
4303 
(2386,6989 
<0.0001 
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3sum of lutein, zeaxanthin, lycopene, alpha carotene, beta carotene, beta 
cryptoxanthin 
4 median energy adjusted dietary lutein/ zeaxanthin (interquartile range) 
* Univariate analysis 
5  p for between category differences in 2058 people with genotyping results for  
rs1061170  
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Table 2 Association of Mediterranean Diet Score (MDS) and nvAMD 
 
 
 
 
 
 
 
 
 
 
1adjusted for age, sex, country, education, smoking, drinking, self-reported history of 
CVD, aspirin consumption, diabetes 
 
2 OR, Odds ratio. 95% CI, 95% Confidence Interval 
 
  
 nvAMD 
 Unadjusted Adjusted1 
MDS score  OR2 (95% CI) OR2 (95% CI) 
≤4 (n=808) 1 (reference) 1 (reference) 
5 ( n=774) 0.88  (0.55-1.39) 0.83 (0.55-1.26) 
6  (n=536) 0.62 (0.33– 1.16) 0.62 (0.39-1.00) 
>6 (n=201)  0.52  (0.29 – 0.93) 0.53(0.27–1.04) 
p trend 0.03 0.01 
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Table 3. Association between Mediterranean Diet Score (MDS) and (i) early AMD 
(grade 1-3) (ii) large drusen (≥125 µm) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 adjusted for age, sex, country, education, smoking, drinking, self-reported history of 
CVD, aspirin consumption, diabetes and body mass index 
2 OR, Odds ratio. 95% CI, 95% Confidence Interval 
 
 
 
 
 All early AMD (grade 1-3) 
MDS score Unadjusted Adjusted1 
 OR (95% CI)2 OR (95% CI)2 
≤4 (n=1506) 1 (reference) 1 (reference) 
5 ( n=1481) 0.99  (0.92-1.07) 1.01 (0.91-1.12) 
6  (n=1021) 0.98 (0.89– 1.08) 1.01 (0.90-1.14) 
>6 (n=380)  0.94 (0.85 – 1.03) 0.96(0.83– 1.11) 
p trend 0.4 0.9 
   
 Large drusen 
≤4 (n=958) 1 (reference) 1 (reference) 
5 ( n=936) 0.96 (0.83-1.11) 0.99 (0.80-1.21) 
6  (n=638) 0.89 (0.70-1.12) 0.90 (0.69-1.17) 
≥6 (n=238)  0.79 (0.65-0.97) 0.80 (0.65-0.98) 
p trend 0.05 0.1 
